Fritz MASL (2011) Clinical gynecologic endocrinology and infertility, 8th edn. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia
Google Scholar
Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, Bühler K et al (2018) Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review. Fertil Steril 109(4):644–664. https://doi.org/10.1016/j.fertnstert.2018.01.003
Article
CAS
PubMed
Google Scholar
Esteves SC, Alviggi C (2015) The role of LH in controlled ovarian stimulation. In: Ghumman S, editor. Principles and Practice of Controlled Ovarian Stimulation in Art. New Delhi: Springer India. p. 171–96.
Aflatoonian A, Yousefnejad F, Eftekhar M, Mohammadian F (2012) Efficacy of low-dose hCG in late follicular phase in controlled ovarian stimulation using GnRH agonist protocol. Arch Gynecol Obstet 286(3):771–775
Article
CAS
Google Scholar
Casarini L, Santi D, Brigante G, Simoni M (2018) Two hormones for one receptor: evolution, biochemistry, actions, and pathophysiology of LH and hCG. Endocr Rev 39(5):549–592. https://doi.org/10.1210/er.2018-00065
Article
PubMed
Google Scholar
Huhtaniemi I (2018) Encyclopedia of endocrine diseases. Academic Press
Google Scholar
Eftekhar M, Khalili MA, Rahmani E (2012) The efficacy of recombinant versus urinary HCG in ART outcome. Iran J Reprod Med 10(6):543
CAS
PubMed
PubMed Central
Google Scholar
Balasch J, Fabregues F (2002) Is luteinizing hormone needed for optimal ovulation induction? Curr Opin Obstet Gynecol 14(3):265–274. https://doi.org/10.1097/00001703-200206000-00004
Article
PubMed
Google Scholar
Hillier SG (2001) Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 179(1-2):39–46. https://doi.org/10.1016/s0303-7207(01)00469-5
Article
CAS
PubMed
Google Scholar
Chappel SC, Howles C (1991) Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 6(9):1206–1212. https://doi.org/10.1093/oxfordjournals.humrep.a137513
Article
CAS
PubMed
Google Scholar
Casarini L, Santi D, Simoni M, Potì F (2018) 'Spare' luteinizing hormone receptors: facts and fiction. Trends Endocrinol Metab 29(4):208–217. https://doi.org/10.1016/j.tem.2018.01.007
Article
CAS
PubMed
Google Scholar
Hillier SG (2000) The Parkes lecture: controlled ovarian stimulation in women. J Reprod Fertil 120(2):201–210. https://doi.org/10.1530/jrf.0.1200201
Article
CAS
PubMed
Google Scholar
Huirne JA, van Loenen AC, Schats R, McDonnell J, Hompes PG, Schoemaker J et al (2005) Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy. Hum Reprod 20(2):359–367. https://doi.org/10.1093/humrep/deh601
Article
CAS
PubMed
Google Scholar
Griesinger G, Schultze-Mosgau A, Dafopoulos K, Schroeder A, Schroer A, von Otte S et al (2005) Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Hum Reprod 20(5):1200–1206. https://doi.org/10.1093/humrep/deh741
Article
CAS
PubMed
Google Scholar
Humaidan P, Bungum M, Bungum L, Yding AC (2004) Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod BioMed Online 8(6):635–643. https://doi.org/10.1016/s1472-6483(10)61643-4
Article
CAS
PubMed
Google Scholar
Levi-Setti PE, Zerbetto I, Baggiani A, Zannoni E, Sacchi L, Smeraldi A et al (2019) An observational retrospective cohort trial on 4,828 IVF cycles evaluating different low prognosis patients following the POSEIDON criteria. Front Endocrinol (Lausanne). 10:282. https://doi.org/10.3389/fendo.2019.00282
Orvieto R (2015) Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom? J Ovarian Res 8:60. https://doi.org/10.1186/s13048-015-0187-6
Article
CAS
PubMed
PubMed Central
Google Scholar
Huseyin K, Berk B, Tolga K, Eser O, Ali G, Murat A (2019) Management of ovulation induction and intrauterine insemination in infertile patients with hypogonadotropic hypogonadism. J Gynecol Obstet Hum Reprod 48(10):833–838. https://doi.org/10.1016/j.jogoh.2019.03.027
Article
PubMed
Google Scholar
Ludwig M (2003) Does the addition of luteinizing hormone in ovarian stimulation protocols improve the outcome? Treat Endocrinol 2(5):305–313. https://doi.org/10.2165/00024677-200302050-00002
Article
CAS
PubMed
Google Scholar
Balasch J, Vidal E, Peñarrubia J, Casamitjana R, Carmona F, Creus M et al (2001) Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod 16(8):1636–1643. https://doi.org/10.1093/humrep/16.8.1636
Article
CAS
PubMed
Google Scholar
Awwad JT, Farra C, Mitri F, Abdallah MA, Jaoudeh MA, Ghazeeri G (2013) Split daily recombinant human LH dose in hypogonadotrophic hypogonadism: a nonrandomized controlled pilot study. Reprod BioMed Online 26(1):88–92. https://doi.org/10.1016/j.rbmo.2012.09.016
Article
CAS
PubMed
Google Scholar
Carone D, Caropreso C, Vitti A, Chiappetta R (2012) Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols. J Endocrinol Investig 35(11):996–1002. https://doi.org/10.3275/8657
Article
CAS
Google Scholar
Kaufmann R, Dunn R, Vaughn T, Hughes G, O'Brien F, Hemsey G et al (2007) Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women. Clin Endocrinol 67(4):563–569. https://doi.org/10.1111/j.1365-2265.2007.02925.x
Article
CAS
Google Scholar
Shoham Z, Smith H, Yeko T, O'Brien F, Hemsey G, O'Dea L (2008) Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study. Clin Endocrinol 69(3):471–478. https://doi.org/10.1111/j.1365-2265.2008.03299.x
Article
CAS
Google Scholar
Munoz E, Bosch E, Fernandez I, Portela S, Ortiz G, Remohi J et al (2012) The role of LH in ovarian stimulation. Curr Pharm Biotechnol 13(3):409–416. https://doi.org/10.2174/138920112799361945
Article
CAS
PubMed
Google Scholar
Krause BT, Ohlinger R, Haase A (2009) Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review. Biologics 3:337–347. https://doi.org/10.2147/btt.2009.3306
Article
CAS
PubMed
PubMed Central
Google Scholar
Mennini FS, Marcellusi A, Viti R, Bini C, Carosso A, Revelli A et al (2018) Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF. Reprod Biol Endocrinol 16(1):68. https://doi.org/10.1186/s12958-018-0386-2
Article
CAS
PubMed
PubMed Central
Google Scholar
Papaleo E, Alviggi C, Colombo GL, Pisanelli C, Ripellino C, Longobardi S et al (2014) Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women. Ther Clin Risk Manag 10:479–484. https://doi.org/10.2147/tcrm.s62351
Article
CAS
PubMed
PubMed Central
Google Scholar
Balasch J, Fábregues F, Carmona F, Casamitjana R, Tena-Sempere M (2009) Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism. J Clin Endocrinol Metab 94(7):2367–2373. https://doi.org/10.1210/jc.2009-0262
Article
CAS
PubMed
Google Scholar
Hillier SG (1994) Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 9(2):188–191. https://doi.org/10.1093/oxfordjournals.humrep.a138480
Article
CAS
PubMed
Google Scholar
Durnerin CI, Erb K, Fleming R, Hillier H, Hillier SG, Howles CM et al (2008) Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Hum Reprod 23(2):421–426. https://doi.org/10.1093/humrep/dem388
Article
CAS
PubMed
Google Scholar
Lossl K, Andersen AN, Loft A, Freiesleben NL, Bangsbøll S, Andersen CY (2006) Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols. Hum Reprod 21(10):2593–2600. https://doi.org/10.1093/humrep/del221
Article
CAS
PubMed
Google Scholar
Balasch J, Fábregues F (2006) LH in the follicular phase: neither too high nor too low. Reprod BioMed Online 12(4):406–415. https://doi.org/10.1016/s1472-6483(10)61991-8
Article
CAS
PubMed
Google Scholar
White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C et al (1996) Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 81(11):3821–3824. https://doi.org/10.1210/jcem.81.11.8923819
Article
CAS
PubMed
Google Scholar
J B. (2004) The role of FSH and LH in ovulation induction: current concepts and the contribution of recombinant gonadotropins. In: Gardner DK, Weissman A, Howles CM, Shoham Z (eds) Textbook of Assisted Reproductive Techniques: Laboratory and Clinical Perspectives 2nd edn. Taylor and Francis, London, pp 541–565
Google Scholar
Simoni MNE (1995) FSH in therapy: physiological basis, new preparations and clinical use. Reprod Med Rev 4:163–177
Article
Google Scholar
Taymor ML (1996) The regulation of follicle growth: some clinical implications in reproductive endocrinology. Fertil Steril 65(2):235–247. https://doi.org/10.1016/s0015-0282(16)58077-7
Article
CAS
PubMed
Google Scholar
Hugues JN, Soussis J, Calderon I, Balasch J, Anderson RA, Romeu A (2005) Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study. Hum Reprod 20(3):629–635. https://doi.org/10.1093/humrep/deh682
Article
CAS
PubMed
Google Scholar
Loumaye E, Engrand P, Shoham Z, Hillier SG, Baird DT (2003) Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Hum Reprod 18(2):314–322. https://doi.org/10.1093/humrep/deg066
Article
CAS
PubMed
Google Scholar
Alviggi C, Conforti A, De Rosa P, Strina I, Palomba S, Vallone R et al (2017) The distribution of stroma and antral follicles differs between insulin-resistance and hyperandrogenism-related polycystic ovarian syndrome. Front Endocrinol (Lausanne) 8:117. https://doi.org/10.3389/fendo.2017.00117
Article
Google Scholar
Copperman AB, Benadiva C (2013) Optimal usage of the GnRH antagonists: a review of the literature. Reprod Biol Endocrinol 11:20. https://doi.org/10.1186/1477-7827-11-20
Article
CAS
PubMed
PubMed Central
Google Scholar
Xiong Y, Bu Z, Dai W, Zhang M, Bao X, Sun Y (2014) Recombinant luteinizing hormone supplementation in women undergoing in vitro fertilization/intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis. Reprod Biol Endocrinol 12(1):109. https://doi.org/10.1186/1477-7827-12-109
Article
CAS
PubMed
PubMed Central
Google Scholar
Baruffi RL, Mauri AL, Petersen CG, Felipe V, Martins AM, Cornicelli J et al (2007) Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis. Reprod BioMed Online 14(1):14–25. https://doi.org/10.1016/s1472-6483(10)60758-4
Article
CAS
PubMed
Google Scholar
Kolibianakis EM, Kalogeropoulou L, Griesinger G, Papanikolaou EG, Papadimas J, Bontis J et al (2007) Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update 13(5):445–452. https://doi.org/10.1093/humupd/dmm008
Article
CAS
PubMed
Google Scholar
Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M (2017) Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Cochrane Database Syst Rev 5(5):Cd005070. https://doi.org/10.1002/14651858.CD005070.pub3
Article
PubMed
Google Scholar
Oliveira JB, Mauri AL, Petersen CG, Martins AM, Cornicelli J, Cavanha M et al (2007) Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRH-agonist protocol: a meta-analysis. J Assist Reprod Genet 24(2-3):67–75. https://doi.org/10.1007/s10815-006-9095-4
Article
PubMed
Google Scholar
Santi D, Casarini L, Alviggi C, Simoni M (2017) Efficacy of follicle-stimulating hormone (FSH) alone, FSH + luteinizing hormone, human menopausal gonadotropin or FSH + human chorionic gonadotropin on assisted reproductive technology outcomes in the "personalized" medicine era: a meta-analysis. Front Endocrinol (Lausanne) 8:114. https://doi.org/10.3389/fendo.2017.00114
Article
Google Scholar
Hill MJ, Levens ED, Levy G, Ryan ME, Csokmay JM, DeCherney AH et al (2012) The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis. Fertil Steril 97(5):1108–1114.e1. https://doi.org/10.1016/j.fertnstert.2012.01.130
Article
CAS
PubMed
Google Scholar
Lehert P, Kolibianakis EM, Venetis CA, Schertz J, Saunders H, Arriagada P et al (2014) Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol 12:17. https://doi.org/10.1186/1477-7827-12-17
Article
CAS
PubMed
PubMed Central
Google Scholar
Acevedo B, Sanchez M, Gomez JL, Cuadros J, Ricciarelli E, Hernández ER (2004) Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles. Fertil Steril 82(2):343–347. https://doi.org/10.1016/j.fertnstert.2004.03.020
Article
CAS
PubMed
Google Scholar
König TE, van der Houwen LE, Overbeek A, Hendriks ML, Beutler-Beemsterboer SN, Kuchenbecker WK et al (2013) Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study. Hum Reprod 28(10):2804–2812. https://doi.org/10.1093/humrep/det266
Article
CAS
PubMed
Google Scholar
Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Pellicer A (2011) Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril 95(3):1031–1036. https://doi.org/10.1016/j.fertnstert.2010.10.021
Article
CAS
PubMed
Google Scholar
Chen LCC-R, Kong X-J, Qiu C-R (2019) Effects of luteinizing hormone supplementation on ovarian response and assisted reproductive technology outcomes in antagonist in vitro fertilization/intracytoplasmic sperm injection cycles: a meta-analysis. Reprod Dev Med 3(2):88–98
Article
Google Scholar
Levi-Setti PE, Cavagna M, Bulletti C (2006) Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH. Eur J Obstet Gynecol Reprod Biol 126(2):212–216. https://doi.org/10.1016/j.ejogrb.2005.11.023
Article
CAS
PubMed
Google Scholar
Humaidan P (2006) To add or not to add LH: comments on a recent commentary. Reprod BioMed Online 12(3):284–285. https://doi.org/10.1016/s1472-6483(10)60998-4
Article
PubMed
Google Scholar
SK (2005) To add or not to add LH: consideration of LH concentration changes in individual patients 11(6):664–6
Vuong TN, Phung HT, Ho MT (2015) Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial. Hum Reprod 30(5):1188–1195. https://doi.org/10.1093/humrep/dev038
Article
CAS
PubMed
Google Scholar
Younis JS, Izhaki I, Ben-Ami M (2016) The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study. Clin Endocrinol 84(1):99–106. https://doi.org/10.1111/cen.12886
Article
CAS
Google Scholar
Gómez-Palomares JL, Acevedo-Martín B, Andrés L, Ricciarelli E, Hernández ER (2005) LH improves early follicular recruitment in women over 38 years old. Reprod BioMed Online 11(4):409–414. https://doi.org/10.1016/s1472-6483(10)61131-5
Article
PubMed
Google Scholar
Conforti A, Esteves SC, Humaidan P, Longobardi S, D'Hooghe T, Orvieto R et al (2021) Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol 19(1):91. https://doi.org/10.1186/s12958-021-00759-4
Article
CAS
PubMed
PubMed Central
Google Scholar
Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC (2007) Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil Steril 87(3):542–546. https://doi.org/10.1016/j.fertnstert.2006.06.059
Article
CAS
PubMed
Google Scholar
Ferraretti AP, Gianaroli L, Magli MC, D'Angelo A, Farfalli V, Montanaro N (2004) Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 82(6):1521–1526. https://doi.org/10.1016/j.fertnstert.2004.06.041
Article
CAS
PubMed
Google Scholar
De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A et al (2005) Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 20(2):390–396. https://doi.org/10.1093/humrep/deh625
Article
CAS
PubMed
Google Scholar
Conforti A, Esteves SC, Di Rella F, Strina I, De Rosa P, Fiorenza A et al (2019) The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis. Reprod Biol Endocrinol 17(1):18. https://doi.org/10.1186/s12958-019-0460-4
Article
PubMed
PubMed Central
Google Scholar
Sheikhha MH, Eftekhar M, Kalantar SM (2011) Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. J Hum Reprod Sci 4(2):86–90. https://doi.org/10.4103/0974-1208.86089
Article
CAS
PubMed
PubMed Central
Google Scholar
Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S et al (2006) FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet 23(4):177–184. https://doi.org/10.1007/s10815-005-9015-z
Article
PubMed
PubMed Central
Google Scholar
Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L (2011) ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 26(7):1616–1624. https://doi.org/10.1093/humrep/der092
Article
CAS
PubMed
Google Scholar
Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K (2007) Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Fertil Steril 88(3):665–669. https://doi.org/10.1016/j.fertnstert.2006.11.150
Article
CAS
PubMed
Google Scholar
Gizzo S, Andrisani A, Noventa M, Manfè S, Oliva A, Gangemi M et al (2015) Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: a cross-matched pilot investigation of the optimal daily dose and timing. Mol Med Rep 12(3):4219–4229. https://doi.org/10.3892/mmr.2015.3904
Article
CAS
PubMed
PubMed Central
Google Scholar
Raju GA, Chavan R, Deenadayal M, Gunasheela D, Gutgutia R, Haripriya G et al (2013) Luteinizing hormone and follicle stimulating hormone synergy: a review of role in controlled ovarian hyper-stimulation. J Hum Reprod Sci 6(4):227–234. https://doi.org/10.4103/0974-1208.126285
Article
CAS
PubMed
PubMed Central
Google Scholar
Musters AM, van Wely M, Mastenbroek S, Kaaijk EM, Repping S, van der Veen F et al (2012) The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve. Hum Reprod 27(1):244–250. https://doi.org/10.1093/humrep/der371
Article
CAS
PubMed
Google Scholar
Barrenetxea G, Agirregoikoa JA, Jiménez MR, de Larruzea AL, Ganzabal T, Carbonero K (2008) Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 89(3):546–553. https://doi.org/10.1016/j.fertnstert.2007.03.088
Article
CAS
PubMed
Google Scholar
Ferraretti AP, Gianaroli L, Motrenko T, Feliciani E, Tabanelli C, Magli MC (2014) LH pretreatment as a novel strategy for poor responders. BioMed research international. 2014:926172. https://doi.org/10.1155/2014/926172
Humaidan P, Alviggi C, Fischer R, Esteves SC (2016) The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome. F1000Res 5:2911. https://doi.org/10.12688/f1000research.10382.1
Article
PubMed
PubMed Central
Google Scholar
Conforti A, Esteves SC, Picarelli S, Iorio G, Rania E, Zullo F et al (2019) Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept. Panminerva Med 61(1):24–29. https://doi.org/10.23736/s0031-0808.18.03511-5
Article
PubMed
Google Scholar
Zeleznik AJF-BD (1994) Control of follicular development, corpus luteum funcion, and the recognition of pregnancy in higher primates. The physiology of reproduction. 2nd ed, Vol 2. Raven Press, New York, pp 751–782
Google Scholar
Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Spettoli D, Taraborrelli S et al (2002) Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. Hum Reprod 17(8):2009–2015. https://doi.org/10.1093/humrep/17.8.2009
Article
CAS
PubMed
Google Scholar
(2001) Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 86(6):2607–2618. https://doi.org/10.1210/jcem.86.6.7599
Caserta D, Lisi F, Marci R, Ciardo F, Fazi A, Lisi R et al (2011) Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation? Gynecol Endocrinol 27(11):862–866. https://doi.org/10.3109/09513590.2010.544133
Article
CAS
PubMed
Google Scholar
Orvieto R (2019) HMG versus recombinant FSH plus recombinant LH in ovarian stimulation for IVF: does the source of LH preparation matter? Reprod BioMed Online 39(6):1001–1006. https://doi.org/10.1016/j.rbmo.2019.08.010
Article
CAS
PubMed
Google Scholar
Trinchard-Lugan I, Khan A, Porchet HC, Munafo A (2002) Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers. Reprod BioMed Online 4(2):106–115. https://doi.org/10.1016/s1472-6483(10)61927-x
Article
CAS
PubMed
Google Scholar
Barberi M, Ermini B, Morelli MB, Ermini M, Cecconi S, Canipari R (2012) Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration. J Assist Reprod Genet 29(12):1381–1391. https://doi.org/10.1007/s10815-012-9893-9
Article
PubMed
PubMed Central
Google Scholar
Gatta V, Tatone C, Ciriminna R, Vento M, Franchi S, d'Aurora M et al (2013) Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone. Fertil Steril 99(7):2000–2008.e1. https://doi.org/10.1016/j.fertnstert.2013.01.150
Article
CAS
PubMed
Google Scholar
Mak SM, Wong WY, Chung HS, Chung PW, Kong GW, Li TC et al (2017) Effect of mid-follicular phase recombinant LH versus urinary HCG supplementation in poor ovarian responders undergoing IVF - a prospective double-blinded randomized study. Reprod BioMed Online 34(3):258–266. https://doi.org/10.1016/j.rbmo.2016.11.014
Article
CAS
PubMed
Google Scholar
Trew GH, Brown AP, Gillard S, Blackmore S, Clewlow C, O'Donohoe P et al (2010) In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review. Reprod Biol Endocrinol 8:137. https://doi.org/10.1186/1477-7827-8-137
Article
CAS
PubMed
PubMed Central
Google Scholar
van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F et al (2012) Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review. Hum Reprod Update 18(2):111. https://doi.org/10.1093/humupd/dmr048
Article
CAS
PubMed
Google Scholar
Camp TA, Rahal JO, Mayo KE (1991) Cellular localization and hormonal regulation of follicle-stimulating hormone and luteinizing hormone receptor messenger RNAs in the rat ovary. Mol Endocrinol (Baltimore, Md) 5(10):1405–1417. https://doi.org/10.1210/mend-5-10-1405
Article
CAS
Google Scholar
Yung Y, Aviel-Ronen S, Maman E, Rubinstein N, Avivi C, Orvieto R et al (2014) Localization of luteinizing hormone receptor protein in the human ovary. Mol Hum Reprod 20(9):844–849. https://doi.org/10.1093/molehr/gau041
Article
CAS
PubMed
Google Scholar
Alviggi C, Pettersson K, Longobardi S, Andersen CY, Conforti A, De Rosa P et al (2013) A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reprod Biol Endocrinol 11:51. https://doi.org/10.1186/1477-7827-11-51
Article
CAS
PubMed
PubMed Central
Google Scholar
Papamentzelopoulou M, Mavrogianni D, Partsinevelos GA, Marinopoulos S, Dinopoulou V, Theofanakis C et al (2012) LH receptor gene expression in cumulus cells in women entering an ART program. J Assist Reprod Genet 29(5):409–416. https://doi.org/10.1007/s10815-012-9729-7
Article
PubMed
PubMed Central
Google Scholar
Yin Q, Li Y, Huang J, Yang D (2015) Association of rs13405728 polymorphism of LHR gene with slow ovarian response. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 32(6):840–843. https://doi.org/10.3760/cma.j.issn.1003-9406.2015.06.020
Article
CAS
PubMed
Google Scholar
Maman E, Yung Y, Kedem A, Yerushalmi GM, Konopnicki S, Cohen B et al (2012) High expression of luteinizing hormone receptors messenger RNA by human cumulus granulosa cells is in correlation with decreased fertilization. Fertil Steril 97(3):592–598. https://doi.org/10.1016/j.fertnstert.2011.12.027
Article
CAS
PubMed
Google Scholar
Desai SS, Achrekar SK, Paranjape SR, Desai SK, Mangoli VS, Mahale SD (2013) Association of allelic combinations of FSHR gene polymorphisms with ovarian response. Reprod BioMed Online 27(4):400–406. https://doi.org/10.1016/j.rbmo.2013.07.007
Article
CAS
PubMed
Google Scholar
Lindgren I, Bååth M, Uvebrant K, Dejmek A, Kjaer L, Henic E et al (2016) Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization. Hum Reprod 31(3):672–683. https://doi.org/10.1093/humrep/dev342
Article
CAS
PubMed
Google Scholar
Lu X, Yan Z, Cai R, Khor S, Wu L, Sun L et al (2019) Pregnancy and live birth in women with pathogenic LHCGR variants using their own oocytes. J Clin Endocrinol Metab 104(12):5877–5892. https://doi.org/10.1210/jc.2019-01276
Article
PubMed
Google Scholar
Alviggi C, Conforti A, Santi D, Esteves SC, Andersen CY, Humaidan P et al (2018) Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis. Hum Reprod Update 24(5):599–614. https://doi.org/10.1093/humupd/dmy019
Article
CAS
PubMed
Google Scholar